Smeets Hugo M, Hoes Arno W, de Wit Niek J
Julius Centrum for Health Sciences and Primary Care, UMC Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
BMC Health Serv Res. 2007 Nov 5;7:177. doi: 10.1186/1472-6963-7-177.
Evaluation of evidence for the effectiveness of implementation strategies aimed at reducing prescriptions for the use of acid suppressive drugs (ASD).
A systematic review of intervention studies with a design according to research quality criteria and outcomes related to the effect of reduction of ASD medication retrieved from Medline, Embase and the Cochrane Library. Outcome measures were the strategy of intervention, quality of methodology and results of treatment to differences of ASD prescriptions and costs.
The intervention varied from a single passive method to multiple active interactions with GPs. Reports of study quality had shortcomings on subjects of data-analysis. Not all outcomes were calculated but if so rction of prescriptions varied from 8% up to 40% and the cost effectiveness was in some cases negative and in others positive. Few studies demonstrated good effects from the interventions to reduce ASD.
Poor quality of some studies is limiting the evidence for effective interventions. Also it is difficult to compare cost-effectiveness between studies. However, RCT studies demonstrate that active interventions are required to reduce ASD volume. Larger multi-intervention studies are necessary to evaluate the most successful intervention instruments.
评估旨在减少抑酸药物(ASD)处方使用的实施策略有效性的证据。
根据研究质量标准和与减少ASD药物使用效果相关的结果,对从Medline、Embase和Cochrane图书馆检索到的干预研究进行系统综述。结果测量指标为干预策略、方法学质量以及ASD处方差异和成本的治疗结果。
干预措施从单一的被动方法到与全科医生的多次主动互动不等。研究质量报告在数据分析主题上存在缺陷。并非所有结果都进行了计算,但如果计算了,处方减少幅度从8%到40%不等,成本效益在某些情况下为负,在其他情况下为正。很少有研究表明干预措施对减少ASD有良好效果。
一些研究质量较差限制了有效干预的证据。此外,研究之间难以比较成本效益。然而,随机对照试验研究表明,需要积极干预以减少ASD的使用量。需要开展更大规模的多干预研究来评估最成功的干预手段。